Literature DB >> 8494879

Activation of human plasma lipid transfer protein by apolipoproteins.

T Ohnishi1, S Yokoyama.   

Abstract

Activation of human plasma lipid transfer protein (LTP) by apolipoproteins was studied. Pyrenelabeled cholesteryl ester was used as a probe substrate for the transfer reaction between lipid microemulsions, with a diameter of 26 nm, of triglyceride and phosphatidylcholine, and the reaction was monitored as a change in the ratio of the peaks of monomer and excimer in the fluorescence spectrum of pyrene. The transfer of pyrene-cholesteryl ester was hardly catalyzed by highly isolated LTP in the absence of apolipoprotein unless extreme overdose of LTP was given, regardless of the presence of bovine serum albumin. Human apolipoprotein (apo) A-I and apoA-II activated the LTP reaction in a dose-dependent manner. The activation was directly proportional to the titration of the surface of the substrate lipid emulsions by the apolipoproteins when the rate was plotted against the apolipoproteins bound to the surface. Human apoE also activated the LTP reaction in the same manner. The activation by human apoC-III was also proportional to the surface-bound protein, but the rate of the transfer was lower than those with other apolipoproteins. Displacement of apoA-I by apoC-III from the lipid emulsion surface, therefore, resulted in apparent deactivation of the LTP reaction. Thus, LTP requires apolipoproteins for its activation, and the activation seems proportional to the area of the surface of the lipid substrate particles modified by apolipoproteins. ApoA-I, -A-II, and -E are more potent activators than apoC-III for cholesteryl ester transfer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494879     DOI: 10.1021/bi00070a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Surface properties of native human plasma lipoproteins and lipoprotein models.

Authors:  J B Massey; H J Pownall
Journal:  Biophys J       Date:  1998-02       Impact factor: 4.033

Review 2.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

3.  Apolipoprotein C-I binds more strongly to phospholipid/triolein/water than triolein/water interfaces: a possible model for inhibiting cholesterol ester transfer protein activity and triacylglycerol-rich lipoprotein uptake.

Authors:  Nathan L Meyers; Libo Wang; Donald M Small
Journal:  Biochemistry       Date:  2012-02-02       Impact factor: 3.162

4.  Effects of charged lipids on the interaction of cholesteryl ester transfer protein with lipid microemulsions.

Authors:  O V Rajaram; W H Sawyer
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

5.  Effect of unesterified cholesterol on the activity of cholesteryl ester transfer protein.

Authors:  O V Rajaram; R Y Chan; W H Sawyer
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

6.  The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

Authors:  S Lusa; M Jauhiainen; J Metso; P Somerharju; C Ehnholm
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.

Authors:  Toshimi Kido; Kazuo Kondo; Hideaki Kurata; Yoko Fujiwara; Takeyoshi Urata; Hiroshige Itakura; Shinji Yokoyama
Journal:  Lipids Health Dis       Date:  2017-11-29       Impact factor: 3.876

8.  Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.

Authors:  Toshimi Kido; Hideaki Kurata; Kazuo Kondo; Hiroshige Itakura; Mitsuyo Okazaki; Takeyoshi Urata; Shinji Yokoyama
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.